| Current assets: |
| Cash and cash equivalents |
53.94M |
| Short-term investments |
52.92M |
| Trade accounts receivable |
20.59M |
| Inventory |
66.43M |
| Prepaid antigen costs |
| Prepaid expenses and other current assets |
| Total current assets |
222.74M |
| Property and equipment, net |
107.78M |
| Long-term investments |
5.18M |
| Other assets |
4.57M |
| Total assets |
340.26M |
| Current liabilities: |
| Accounts payable |
12.68M |
| Accrued liabilities |
24.53M |
| Accrued compensation |
18.22M |
| Convertible senior notes due 2016 |
| Current portion of capital lease obligations |
2.44M |
| Current portion of facility lease obligations |
674K |
| Total current liabilities |
63.52M |
| Long-term accrued liabilities |
5.71M |
| Capital lease obligations, less current portion |
1.58M |
| Facility lease obligations, less current portion |
9.56M |
| Convertible senior subordinated notes due 2014 |
| Commitments and contingencies (Note 10) |
| Stockholders' equity: |
| Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued or outstanding |
0 |
| Common stock, $0.001 par value; 250,000,000 shares authorized, 148,866,750 and 147,447,208 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively |
155K |
| Additional paid-in capital |
2B |
| Accumulated other comprehensive income |
18K |
| Accumulated deficit |
-2.32B |
| Total stockholders' equity |
-320.47M |
| Total liabilities and stockholders' equity |
340.26M |
